Genetic Technologies
GENE
#10839
Rank
โ‚น0.35 B
Marketcap
โ‚น72.42
Share price
0.00%
Change (1 day)
-65.58%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.15 a decrease over its 2022 EPS that were of -โ‚น2.09.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.1550.65%
2022-โ‚น2.09-99.04%
2021-โ‚น217.11-46.67%
2020-โ‚น407.07-99.38%
2019-โ‚น65,13210809.09%
2018-โ‚น597.04-41.07%
2017-โ‚น1,013-18.37%
2016-โ‚น1,241-40.24%
2015-โ‚น2,077-53.41%
2014-โ‚น4,458-10.66%
2013-โ‚น4,99071.3%
2012-โ‚น2,913-622.73%
2011โ‚น557.24-108.8%
2010-โ‚น6,332-3.92%
2009-โ‚น6,59173.47%
2008-โ‚น3,79924.96%
2007-โ‚น3,040-10.93%
2006-โ‚น3,413-48.62%
2005-โ‚น6,644-8.31%
2004-โ‚น7,246
2003N/A-100%
2002-โ‚น4,499-9.36%
2001-โ‚น4,964

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,725N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น868.11N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น491.33N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,075N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.40N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น265.69N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น409.91N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,262N/A๐Ÿ‡บ๐Ÿ‡ธ USA